Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta: Gender difference and effect of estrogen receptor gene disruption

Journal of Clinical Investigation

Volumn 99, Issue 10, 1997, Pages 2429-2437

  Rubanyi, Gabor M ^a   Freay, Ana D ^a   Kauser, Katalin ^a   Sukovich, Drew ^a   Burton, Gerardine ^c   Lubahn, Dennis B ^d   Couse, John F ^b   Curtis, Sylvia W ^b   Korach, Kenneth S ^b  

^a BAYER AG   (Germany)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c BAYER PHARMA AG   (Germany)

^d University of Missouri   (United States)

Author keywords

125I 17 estradiol binding; ERKO mice; estrogen receptor; gender difference; nitric oxide synthase

Indexed keywords

ESTROGEN RECEPTOR; NITRIC OXIDE;

ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; GENDER; HYPERTENSION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030962333     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119426     Document Type: Article

References (43)

1. Adams, M.R., J.F. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, M.S. Wolfe, and T. Clarkson. 1990. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Arteriosclerosis. 10:1051-1057.
2. Iams, S.O., and B.C. Wexler. 1979. Inhibition of the development of spontaneous hypertension in SH rats by gonadectomy or estradiol. J. Lab. Clin. Med. 10:608-616.
3. Stampfer, M.J., G.A. Coldiz, W.C. Willett, J.E. Manson, B. Rosner, F.E. Speizer, and C.H. Hennekens. 1991. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurse's Health Study. N. Engl. J. Med. 325:756-762.
4. Van Buren, G.A., D.S. Yang, and K.E. Clark. 1992. Estrogen-induced vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am. J. Obstet. Gynecol. 167:828-833.
5. von Eiff, A.W., E. Gogolin, U. Jacobs, and H. Neus. 1986. Ambulatory blood pressure in children followed up after 3 years: influence of sex and family history on hypertension. Clin. Exp. Hypertens. 8:577-581.
6. Gisclard, V., V.M. Miller, and P.M. Vanhoutte. 1988. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244:9-22.
7. Hayashi, T., J.M. Fukuto, J.L. Ignarro, and G. Chaudhuri. 1992. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc. Natl. Acad. Sci. USA. 89:11259-11263.
8. Kauser, K., and G.M. Rubanyi. 1994. Gender difference in bioassayable endothelium-derived nitric oxide release from isolated rat aortae. Am. J. Physiol. 267:H2311-H2317.
9. Williams, J.K., M.R. Adams, and H.S. Klopfenstein. 1990. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 81:1680-1687.
10. Hishikawa, K., B. Nakaki, T. Marumo, H. Suzuki, R. Kato, and T. Saruta. 1995. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:291-293.
11. Weiner, C.P., R.G. Knowles, and S. Moncada. 1994. Induction of nitric oxide syntases early in pregnancy. Am. J. Obstet. Gynecol. 171:838-843.
12. Conrad, K.P., P.M. Joffe, H. Kruszyna, L.G. Rochelle, R.P. Smith, J.E. Chavez, and M.D. Mosher. 1993. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 7:566-571.
13. Kauser, K., and G.M. Rubanyi. 1994. 17β-estradiol and endothelial nitric oxide synthase. Endothelium. 2:203-208.
14. Lieberman, E.H., M.D. Gerhard, A. Uehata, B.W. Walsh, A.P. Selwyn, P. Ganz, A.D. Yeung, and M.A. Creager. 1994. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann. Intern. Med. 121:936-941.
15. Rosselli, M., B. Imthurn, P.J. Keller, E.K. Jackson, and R.K. Dubey. 1995. Circulating nitric oxide (nitrate/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two year follow-up study. Hypertension (Dallas). 25:848-853.
16. Colburn, P., and V. Buonassisi. 1978. Estrogen-binding sites in endothelial cell cultures. Science (Wash. DC). 201:817-819.
17. Horwitz, K.B., and C.D. Horwitz. 1982. Canine vascular tissues are targets for androgens, estrogens, progestins, and gluocorticoids. J. Clin. Invest. 69: 750-758.
18. Lin, A.L., H.C. McGill, and S.A. Shain. 1982. Hormone receptors of the baboon cardiovascular system. Circ. Res. 50:610-616.
19. Perrot-Applanat, M., M.T. Groyer-Picard, E. Garcia, F. Lorenzo, and E. Milgrom. 1988. Immunochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology. 123:1511-1519.
20. Losordo, D.W., M. Kearney, E.A. Kim, J. Jekanowski, and J.M. Isner. 1994. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1501-1510.
21. Lubahn, D.B., J.S. Moyer, T.S. Golding, J.F. Course, K.S. Korach, and O. Smithies. 1993. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. USA. 90:11162-11166.
22. Korach, K.S. 1994. Insights from the study of animals lacking functional estrogen receptor. Science (Wash. DC). 266:1524-1527.
23. Couse, J.F., S.W. Curtis, T.F. Washburn, J. Lindzey, T.S. Golding, D.B. Lubahn, O. Smithies, and K.S. Korach. 1995. Analysis of transcription and cstrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol. Endocrinol. 9:1441-1454.
24. Korach, K.S. 1979. Estrogen action in the mouse uterus: characterization of the cytosolic and nuclear receptor system. Endocrinology. 104:1324-1332.
25. Golding, T.S., and K.S. Korach. 1988. Nuclear estrogen receptor molecular heterogeneity in the mouse uterus. Proc. Natl. Acad. Sci. USA. 85:69-73.
26. Mulvany, M.J., and W. Halpern. 1977. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res. 41:19-26.
27. Bredt, D.S., and S.H. Snyder. 1989. Nitric oxide mediated glutamatelinked enchancement if cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA. 86:9030-9033.
28. Bradford, M.M. 1976. A rapid and sensitive method for the quantification of protein dye binding. Anal. Biochem. 72:700-703.
29. Chomczynski, P., and N. Sacchi. 1987. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
30. Furchgott, R.F., and J.V. Zawadzki. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond.). 288:373-376.
31. Rubanyi, G.M., and P.M. Vanhoutte, editors. 1990. Endothelium-derived relaxing factors. Karger AG, Basel, Switzerland. 1-337.
32. Griffith, T.M., D.H. Edwards, and A.H. Henderson. 1987. Unstimulated release of endothelium derived relaxing factor is independent of mitochondrial ATP generation. Cardiovasc. Res. 21:565-568.
33. Rubanyi, G.M., R.R. Lorenz, and P.M. Vanhoutte. 1987. Bioassay of endothelium-derived relaxing factor(s):inactivation by catecholamines. Am. J. Physiol. 249:H95-H101.
34. Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
35. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowits, J.A. Bevan, and M.C. Fisherman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (Lond.). 377:239-242.
36. Rubanvi, G.M., editor. 1991. Cardiovascular Significance of Endothelium-Derived Vasoactive Factors. Futura Publishing Co., Armonk, NY. 357 pp.
37. Rubanyi, G.M. 1993. Role of endothelium in cardiovascular homeostasis and diseases. J. Cardiovasc. Pharmacol. 22 (Suppl.4):S1-S13.
38. Paigen, B., P.A. Holmes, D. Mitchell, and D. Albee. 1986. Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c and C3H. Atherosclerosis. 64:215-221.
39. Sudhir, K., G.L. Jennings, J.W. Funder, and P.A. Komesaroff. 1995. Estrogen supplementation enhances basal release of nitric oxide in the forearm vasculature of perimenopausal women (abstr.) Circulation. 92:I-68.
40. G-nitro-L-arginine methyl ester of basal and agonist stimulated EDRF activity. Br J. Pharmacol. 104:743-749.
41. Lantin-Hermoso,R.L., C.R. Rosenfeld, Z. German, Z. Chen, and P.W. Shaul. 1995. Estrogen acutely enhances nitric oxide syntase activity in fetal pulmonary artery endothelium. Circulation. 92:I-6 (Abstr.)
42. Busse, R., K. Ayajik, M. Kindermann, M. Hecker, I. Fleming. 1996. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ. Res. 78: 750-758.
43. Bender, J. 1996. Presentation on the Symposium "Estrogen and Vessel Wall." 3-4 September 1996. Seattle, WA.